“Reports Of Inequities In Distribution Of Covid-19 Vaccines Are Completely Baseless”: Dr. Harsh Vardhan

On Saturday, Dr. Harsh Vardhan tweeted that the report of inequities in distribution of covid-19 vaccines are completely baseless. He further added that in the month of May’ 21, the private hospitals across the country, have received over 1.2 crore doses in a very transparent manner and they constantly helping to drive efficiency in World’s Largest Vaccination Drive.

The press release shared by the Dr. Vardhan, said that the media reports which are alleging vaccine inequity in India’s vaccination drive are inaccurate and speculative in nature.

It further said that a ‘Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy’ which is guiding the current ongoing Phase-III of covid-19 vaccination drive was adopted on 1st May 2021 and it proposes a larger role for the private sector.

“Centre is setting aside 25% vaccines for the the private sector & the hospital which contracted with M/S Serum Institute Of India & M/S Bharat Biotech have been supplied with doses of Covishield and Covaxin. These private hospitals are also from Tier II and Tier III cities apart from bigger metro cities.” said the press release by Ministry of Health and Family Welfare.

It further reiterated that the “Ministry Of Health And Family Welfare is working closely with all the States and UT’s to make the India’s Covid-19 Vaccination Drive a success. It also requested the states with less number of private hospitals to review the status and list out the better performing hospitals AB-PMJAY and encourage them to get in agreement with the vaccine manufactures.

This comes after the new vaccine policy got sharp criticism from various state governments and the opposition that have demanded the Centre to provide the vaccine free of cost.

Recently, the remark of “prima facie arbitrary and irrational” came from the Supreme Court over the Centre’s policy of vaccination people those above 45 years for free of cost and paid for the age group of 18-44.

Also Read: No Deaths in Patients Re-infected after Covid Vaccination, Shows AIIMS Study